SAVA FY 2014 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$7,306

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-1.92

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$41M

Total Liabilities

$850,000

Stockholders' Equity

$40M

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$41M	-100.0%
Gross Profit	-$7,306	$41M	-100.0%
Operating Income	-$12M	$31M	-139.6%
Net Income	-$12M	$32M	-139.3%